- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04580810
Black Church Treatment Study
Addressing Health Disparities by Providing Evidence-Based Treatment in the Black Church
This study will conduct a randomized clinical trial comparing levels of treatment initiation, engagement, and alcohol outcomes for a novel treatment strategy (CBT4CBT delivered in the Black church) compared with traditional outpatient specialty addiction treatment for a large sample of Black adults with AUD.
The purpose of this randomized clinical trial is to determine which setting (church or specialty clinic) (1) has better treatment initiation and retention rates and (2) better AUD outcomes as measured by percentage of days abstinent (PDA) (8 weeks, 3, 6 and 9 months follow up).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized control trial focusing on rates of treatment initiation, engagement, and outcome in Black adults assigned to CBT4CBT in the Black Church relative to the standard of care for this population. This study is focusing on individuals with AUD as the needs assessment indicated that as the most common substance use problem in this setting. Moreover, our focus groups and work with Church staff has indicated that alcohol use is less stigmatized within the Black and the Church communities than other substance use. Thus, while individuals with other substance use will be included, positioning the study as focusing primarily on alcohol use will avoid potential issues of stigma and thus may facilitate recruitment.
Selecting a comparison condition for this novel intervention strategy is complex.
As the primary rationale for delivering treatment in the Black church setting is that this national network is seen as a trusted institution in the Black community, our research questions center around (1) whether delivering CBT4CBT in the Black church is a safe and effective alternative to standard care, (2) whether it engages and retains individuals better than standard specialty care, (3) the extent to which this strategy reaches individuals who would not otherwise seek treatment for AUD, (4) what kinds of individuals are particularly suited to this setting, and (5) the relative costs of this novel form of treatment delivery. Thus, a standard specialty care at Midwestern Connecticut Council on Alcohol (MCCA) as the comparison condition was selected. MCCA is a non-profit, community-based provider in the predominantly Black Dixwell neighborhood, not far from Dixwell Church and has a positive reputation in the Black community. The primary treatment modality is group therapy. In 2019, MCCA treated over 500 unique individuals (44% female, 35% African American, 20% Latino). MCCA staff are diverse and multidisciplinary. Clinic Director Steven Palma has agreed to provide a dedicated triage slot for this study so individuals can be admitted and assigned a group within one week, reducing a key barrier.
The two study settings will be balanced in several ways, with few barriers to care, both in the same neighborhood, and assignment of participants to a group within one week of randomization, thus preserving equipoise and balancing attractiveness of both sites to participants as much as possible. They will differ primarily in setting (church versus specialty care), in treatment content (CBT4CBT with spirituality elements versus group treatment with some CBT content), and group leaders (CHAs versus masters-level staff).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Traci Norman
- Phone Number: 203-833-4267
- Email: Traci.Norman@nyulangone.org
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06511
- Recruiting
- Beulah Heights First Pentecostal Church
-
Contact:
- Blanche Tucker
- Phone Number: 203-996-2061
- Email: blanche.tucker@sbcglobal.net
-
New Haven, Connecticut, United States, 06511
- Recruiting
- Dixwell Ave Congregational United Church of Christ
-
Contact:
- Fredrick Streets
- Phone Number: 203-787-5839
- Email: ayana.jordan@yale.edu
-
New Haven, Connecticut, United States, 06511
- Recruiting
- The Substance Abuse Training Unit (SATU)
-
Contact:
- Donna Lapaglia
- Phone Number: 203-974-5734
- Email: donna.lapaglia@yale.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- at least 18 years of age
- current AUD as their principal substance use disorder, confirmed via MINI100 interview, with some drinking in the past 28 days
- English-speaking
Exclusion Criteria:
- inability to provide informed consent or participate in the study procedures as proposed in the consent
- active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder),
- current engagement in substance use treatment, and
- an unwillingness to be randomized to either condition. Individuals with comorbid substance use disorders will be included, as multiple substances of use are common in this population.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CBT4CBT in the Black Church
The 'CBT for CBT' program is modeled closely on our NIDA-published CBT manual. Seven core skill modules will cover the following topics, which correspond to the major session topics in the manual: Understanding and changing patterns of alcohol use, Coping with craving, Substance refusal skills, Seemingly irrelevant decisions, Planning for emergencies, and Problem-solving skills. Staying Safe |
Use of Computer Based Treatment for Cognitive Behavioral Therapy for alcohol use disorder offered in a Black church setting
|
No Intervention: Community Based Treatment as Usual
Treatment as usual, typically groups, offered by a specialty community based treatment center (MCCA)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rates of treatment initiation
Time Frame: 8 weeks
|
Rates of treatment initiation as measured by proportion of participants completing at least one session at the assigned site
|
8 weeks
|
Rates of engagement in treatment
Time Frame: 8 weeks
|
Rates of engagement in treatment operationalized by proportion retained at the 4-week point at the assigned site
|
8 weeks
|
Percent days abstinent from alcohol
Time Frame: 8 weeks
|
Percent days abstinent from alcohol operationalized by Timeline Follow Back
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ayana Jordan, MD, PhD., NYU Langone Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-01366
- R01AA028778-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Kaiser PermanenteNORC at the University of Chicago; Agency for Healthcare Research and Quality... and other collaboratorsCompleted
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Central Institute of Mental Health, MannheimNot yet recruitingAlcohol Use Disorder (AUD)Germany
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompletedAlcohol Use Disorder (AUD)Uganda
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingNeurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use DisorderAlcohol Dependence | Alcohol-Related Disorders | Substance Use Disorders | Drug Abuse | Mental Disorder | Alcohol Abuse | Alcohol Use Disorder (AUD)
Clinical Trials on CBT4CBT in the Black Church
-
Cedars-Sinai Medical CenterCalifornia Breast Cancer Research ProgramRecruitingFaith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean WomenHealth Knowledge, Attitudes, Practice | Breast Cancer Female | Health Disparities | Cancer ScreeningUnited States
-
St. Louis UniversityMid-America TransplantRecruitingChronic Kidney Diseases | Genetic Predisposition | NephropathyUnited States
-
University of Alabama at BirminghamNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Poznan University of Physical EducationCompletedInflammation | Oxidative Stress | Female Athlete Triad | Iron DeficienciesPoland
-
Rajiv Gandhi Cancer Institute & Research Center...UnknownRobotic Surgical ProceduresIndia
-
University of Nove de JulhoUnknownMultiple SclerosisBrazil
-
Cairo UniversityUnknownGingival Black TriangleEgypt
-
University of RochesterNational Institutes of Health (NIH)RecruitingStroke, Ischemic | Stroke Hemorrhagic | Visual Field Defect, Peripheral | Hemianopsia | Hemianopia | Quadrantanopia | Homonymous Hemianopia | Occipital Lobe Infarct | Visual Fields Hemianopsia | Vision Loss Partial | Peripheral Visual Field Defect of Both Eyes | Peripheral Visual Field Defect | Homonymous Hemianopsia and other conditionsUnited States
-
University of RochesterNational Eye Institute (NEI)Active, not recruitingStroke, Ischemic | Hemianopia | Quadrantanopia | Vision Loss Partial | Hemianopia HomonymousUnited States
-
Cerebra MedicalUniversity of ManitobaSuspended